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Abstract Purpose: The traditional approach for identifying subjects at risk from cardiovascular diseases (CVD) is*Address correspo
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doi:10.1016/j.jadohealto determine the extent of clustering of biological risk factors adjusted for lifestyle. Recently, markers of
endothelial dysfunction and low grade inflammation, including high sensitivity C-reactive protein
(hsCRP), soluble intercellular adhesion molecules (sICAM), and soluble vascular adhesion molecules
(sVCAM), have been included in the detection for high risk individuals. However, the relationship of these
novel biomarkers with CVD risk in adolescents remains unclear. The purpose of this study, therefore, was
to establish the association of hsCRP, sICAM, and sVCAM with CVD risk in an adolescent population.
Methods: Data from the Young Hearts 2000 cross-sectional cohort study, carried out in 1999–2001,
were used. From a total of 2,017 male and female participants, 95 obese subjects were identified and
matched according to age, sex, and cigarette smoking, with 95 overweight and 95 normal-weight
adolescents. Clustered CVD risk was computed using a sum of Z-scores of biological risk factors.
The relationship was described using multiple linear regression analyses.
Results: hsCRP, sICAM, and sVCAM showed significant associations with CVD risk. hsCRP and
sICAM had a positive relation with CVD risk, whereas sVCAM showed an inverse relationship. In
this study, lifestyle factors showed no relation with CVD risk.
Conclusion: The results fit the hypothesized role of low grade inflammation and endothelial dysfunc-
tion in CVD risk in asymptomatic adolescents. The inverse relationship of VCAM, however, is hard to
explain and indicates the complex mechanisms underlying CVD. Further research is needed to draw
firm conclusions on the biomarkers used.  2010 Society for Adolescent Health and Medicine.
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Open access una shortened life span. To prevent CVD, pre-emptive interven-
tions aimed at lifestyle habits from an early age are required,
before associated pathologies become established [1–3]. The
classical approach to detect subjects at risk is to determine
the presence of biological risk factors such as blood pressure
and cholesterol level, and lifestyle risk factors such as
physical activity and daily caloric intake [4–6]. These
classical risk factors tend to cluster and work synergistically,der CC BY-NC-ND license.
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factors in isolation. Therefore, CVD risk clusters are
especially useful in the detection of high risk individuals
[7–9]. Recently, CVD risk has been refined by including
various markers indicative of low grade inflammation and
endothelial dysfunction [10–12]. The practical usefulness of
these markers derives from their appearance in the early
stages of a causative pathway of obesity-related vascular
damage [11,13].
So far, the systemic inflammation marker, high sensitivity
C-reactive protein (hsCRP), has been shown to be upregulated
in pre-clinical as well as advanced stages of vascular
damage [14,15]. Markers specific for endothelial dysfunction
are soluble vascular adhesion molecules (sVCAM) and
intercellular (sICAM) adhesion molecules [3,13,16,17].
Although the physiological mechanism of sICAM and
sVCAM in endothelial damage remains obscure, it is
associated with upregulation of sCAMs in different stages of
vascular damage [3,16,17]. However, although the single
markers have been found to be related to several CVD risk
factors in adult populations, the association with CVD risk in
adolescents is unknown. The aim of this study, therefore,
was to examine the relationship of hsCRP, sICAM, and
sVCAM with CVD risk in adolescents, independent of the
widely accepted biological and lifestyle risk factors.
Information on CVD risk in adolescents is important as it
may direct preventive strategies. Additionally, it may provide
a valuable insight in the etiology of inflammation, premature
atherosclerosis, and childhood adiposity.Study population and methods
Study population
The Young Hearts Project 2000 is a cross-sectional cohort
study which took place in 1999–2001 following a previous
study, Young Hearts I, described in detail elsewhere [18].
The Young Hearts Project 2000 had a total of 2,017 partici-
pants from Northern Ireland, consisting of 12- and 15-year-
olds from 36 nationally representative schools; the response
rate was 65.4%. Eligible subjects were selected using
a computer-generated random number list, divided into
groups according to age and gender, resulting in approxi-
mately 500 participants in each of the four age/sex groups.
Age was defined as years of age 6 6 months (e.g., a 12-
year-old child ranges from 11.5 to 12.5 years). Inflammation
markers were only measured in a subsample of the total pop-
ulation. In this subsample, a distinction was made between
normal, overweight, and obese subjects (according to the
classification by Cole et al. [19]). The prevalence of over-
weight and obesity in the complete cohort was 16.2% and
14.7%, respectively. In the present study sample, all obese
adolescents (n ¼ 95) were selected and matched according
to age, gender, and smoking status, with overweight and
normal weight children. Because of problems in obtaininga blood sample from three of the obese adolescents, the final
number of participants in each of the three groups was
reduced to 92. The total number of participants in this study
was therefore ¼ 276.
Ethical approval was obtained from the Research Ethics
Committee of Queens University Belfast. Written informed
consent was signed by the participants and the participants’
parent or guardian.Surveys and measurements
For each child, the examination included a medical
examination, cardiorespiratory fitness test, dietary examina-
tion, and a parental and physical activity questionnaire. The
medical examination included weight (nearest 100 g, Seca
770 electronic weighing scale) and height (nearest mm,
Holtain stadiometer) using standard techniques, with partici-
pants in light clothing and without shoes. Pubertal status was
visually assessed using Tanner pubic hair development
stages [20]. Body mass index was calculated as weight
(kg)/height2 (m).
Peripheral venous blood (w16 mL) was obtained by vene-
puncture in fasting state and collected into serum-z-clot
activator EDTA-sodium or lithium heparin-coated tubes.
Samples were transported in a chilled insulated container,
and serum/plasmawas removed after centrifugation at 1003 g
for 10 minutes at 4C within 4 hours from venepuncture and
stored at70C.Clustered CVD risk
Because CVD risk is seldom clinically defined at this age,
a clustered score for biological risk factor can be used to specify
subjects at risk [7–9]. Clustered CVD risk in the present
study was computed using scores for mean arterial pressure
(MAP), LDL:HDL cholesterol ratio, cardiorespiratory fitness,
skinfolds, and triglyceride levels. Blood pressure was
measured twice from the right arm using a Hawksley random
zero sphygmomanometer, with subjects sitting down quietly
beforehand for at least 5 minutes. Systolic blood pressure (SB)
was recorded as the mean of the two values for Korotkoff
phase 1, whereas the diastolic blood pressure (DB) was based
on the mean of the two values for Korotkoff phase V (15-
year-old) or phase IV (12-year-old). Mean arterial pressure
was defined as [2DB þ SB]/3). Total plasma-cholesterol,
HDL-cholesterol, and plasma triglyceride were determined
(Boeringer, Mannheim, Germany; Cobas Fara automated
analyzer) according to the World Health Organization (WHO)
standards of quality control. Four skinfold thickness measure-
ments (triceps, biceps, subscapula, and suprailiac; mm) were
taken in duplicate on the left side of the body according to Dur-
nin andRahaman [21].Cardiorespiratoryfitnesswasdetermined
with the 20-meter endurance shuttle test. Subjects ran a distance
of 20m at a fixed speed, and the pace was increased by .5 km/hr
everyminute. The score was recorded as the number of success-
fully completed laps at voluntary exhaustion [22].
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Lifestyle factors were physical activity, caloric intake,
and smoking status. Physical activity was estimated by
a self-administered recall questionnaire under the supervision
of an exercise physiologist. The questionnaire assessed
frequency, intensity, and duration of habitual activity and
allocated scores out of 100 [18,23–25]. Dietary information
was recorded by a nutritionist using a 7-day recall diet
history interview [26]. Each nutritionist consulted with
a similar number of participants from each group, and inter-
observer reproducibility was confirmed before sampling.
The mean daily caloric intake (kcals) was calculated from
the 7-day recall diet history interview using the nutrition anal-
ysis software programmeWISP (Tinuviel Software,Warring-
ton, UK), and recorded for each subject. Smoking status was
determined using a self-administered questionnaire on
smoking and daily number of cigarettes smoked.Inflammation markers
Plasma levels of sICAM and sVCAM were determined
using commercially available monoclonal ELISA kits
(Diaclone, Immunodiagnostic Systemd, Ltd) according to
the recommendations of the manufacturer. Mean inter-
assay coefficients of variation for sICAM and sVCAM
ELISAs were 4.7% and 4.2%, respectively. Plasma hsCRP
was quantified by a high sensitivity latex-enhanced immuno-
turbidimetric assay (Wako Chemicals GmbH) using a Cobas
Fara automated analyzer (Roche Diagnostics, UK). The intra-
assay and inter-assay coefficients of variation were 5.0%.Table 1
Descriptive information on CVD risk, lifestyle factors and inflammation markers i
Boys
12 years
n ¼ 80
BMI 24.2 (5.2)
Tanner stage
<3 98.7
>3 1.3
Sum4Skinfolds (mm) 64.4 (32.0)
MAP (2DB þ SB)/3 (mm Hg) 97.2 (11.8)
Systolic blood pressure (mm Hg) 113 (14.2)
Diastolic blood pressure (mm Hg) 65.5 (9.0)
LDL/HDL cholesterol ratio .29 (.23–.34
LDL cholesterol (mg/dL) 3.0 (.75) (¼
HDL cholesterol (mg/dL) 1.2 (.34) (¼
Triglyceride (mmol/L) .85 (.63–1.1
Cardiorespiratory fitness (20-MST: number of laps) 54 (38–77)
Total Z score (age and sex specific) 0.0 (3.5)
Physical activity (Baecke score) 30.5 (15.9)
Energy intake (kcal) 2797 (886)
Smoking 5%
sICAM (mg/L) 836 (191)
sVCAM (mg/L) 1070 (227)
hsCRP (mg/L) .87 (.99)
BMI ¼ body mass index; MAP ¼ mean arterial pressure; 20-MST ¼ 20-meter
Data are mean 6 standard deviation (SD) or median (interquartile range) for coThe operator was blinded to sample classification for all
laboratory procedures.
Statistical analyses
Clustered CVD risk scores were computed using a sum of
age- and gender-specific z-scores. Triglyceride, cholesterol
ratio, and cardiorespiratory fitness measures were log
transformed to meet the assumption of normal distribution.
The existence of clustering between the biological risk
factors was determined with pair-wise Pearson correlation
coefficients.
To determine whether inflammation markers relate to
clustered CVD risk independent of established lifestyle risk
factors, linear regression analyses were used. Regression
analyses required that each participant had a complete dataset
for all variables. Missing data were not imputed because of
the small numbers of missing data. The total number of
participants included in the regression analyses was n ¼
251. First, univariate analyses were performed to analyze
the relationship between single determinants and clustered
CVD risk. Second, a multiple regression analysis with
a forward selection procedure was performed in which both
lifestyle risk factors and inflammation markers were included
as possible determinants. A threshold significance value of
10% (p ¼ .10) was assigned for the inclusion of variables
in the final prediction model.
R2 were used to give an indication of the quality of the
final prediction model. All statistical analyses were per-
formed in Statistical Package for the Social Sciences (SPSS
Inc, Chicago, IL), version 16.0.n the Young Hearts 2000
Girls
15 years 12 years 15 years
n ¼ 46 n ¼ 82 N ¼ 68
25.0 (5.1)
26.1 91.4 4.4
73.9 8.6 95.6
71.8 (28.3)
96.6 (11.8)
112 (14.0)
66.4 (9.8)
) .31 (.26–.37)
.08 mmol/L) 2.9 (.67) (¼ .08 mmol/L)
.03 mmol/L) 1.3 (.29) (¼ .03 mmol/L)
0) .75 (.52–1.10)
34 (26–50)
0.0 (3.4)
21.8 (12.4)
2489 (942)
18%
746 (193)
995 (236)
.77 (.95)
endurance shuttle test.
ntinuous variables or percent for dichotomous/categorical variables.
Table 2
Pearson correlation matrix of CVD risk variables
Blood pressure Triglycerides Cholesterol ratio Low Fitness
Triglycerides .27*
Cholesterol ratio .37* .53*
Low cardio-respiratory Fitness .17* .15* .18*
Sum 4 Skinfolds .54* .41* .43* .49*
Correlations* (r) are significant (p < .05); total n ¼ 251.
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Table 1 shows descriptive information for all variables
measured within the present study.
Table 2 shows the pair-wise Pearson correlation matrix for
the biological risk factors. On the basis of the partial correla-
tions, clustering of biological risk factors seems to exist, that
is, all Pearson correlations between the biological risk factors
were positive and significant. Table 3 shows the pair-wise
Pearson correlation matrix for inflammation markers with
univariate and clustered CVD risk variables.
Table 4 shows the results of the crude and multiple regres-
sion analyses. No significant associations were found for the
lifestyle variables. Inflammation markers, however, did show
significant associations with clustered CVD risk. The best
prediction model included hsCRP, sICAM, and sVCAM
and showed an explained variance of 26 %.Table 3
Pearson correlation matrix of inflammation markers with univariate and
clustered CVD risk variables
ICAM VCAM hsCRP
Cholesterol ratio .23* .09 .21*
Triglycerides .34* .03 .21*
Low cardio repiratory Fitness .21* 10 .30*
Blood pressure .05 .12 .05
Sum 4 Skinfolds .24* .23* .38*
Total Z score for CVD risk .34* .16* .39*
Correlations* (r) are significant (p < .05); total n ¼ 251.Discussion
To our knowledge, this is the first study to associate
markers of inflammation and endothelial dysfunction with
clustered CVD risk in adolescents. The main finding of this
study was that these markers were strong predictors for
CVD risk in adolescents, unlike lifestyle factors which
were not predictive.
We studied three markers of low grade inflammation and
endothelial dysfunction. However, not all these markers
showed similar patterns of association with CVD risk. The
markers sICAM and hsCRP were positively related to CVD
risk, whereas an inverse relation for sVCAM was found.
This unexpected inverse relation can possibly be explained in
two ways. First, membrane-bound ICAM and VCAM are
involved in leukocyte adhesion and migration to the vessel
wall as seen in atherosclerosis [3,16,27]. These markers,
however, cannot be easily measured without invasive
techniques. Therefore, soluble adhesion molecules (sCAM)
are used as a surrogate for membrane bound levels, based on
the assumption that soluble levels are indicative of the
processes at the endothelium. Although the soluble markers
have previously been found to be elevated in children at risk,
there is no guarantee that the elevated levels solely indicate
vascular damage. Elevated levels could also indicate other
events, for instance renal dysfunction [3]. Second, there is
a difference in origin of sICAM and sVCAM. Although
sVCAM is mainly a product of endothelial cells, sICAM is
produced by many other cell types throughout the body[16,17]. Current understanding of the roles and effects of
sICAM and sVCAM remains incomplete. Some studies
have found that the contribution of sICAM and sVCAM
in atherosclerosis is similar, whereas others have found
high expression of sICAM in healthy subjects associated
with CVD risk and high levels of sVCAM in ongoing stages
of atherosclerosis and CVD outcomes [3,17,28–30]. Such
associations of VCAM need not exist in a healthy adolescent
population as currently used. The inverse relation of sVCAM
as found in the current study could, therefore, indicate lower
incidence of ongoing stages of vascular damage in this
population.
Limitations of the study design merit consideration.
Although the study provides a representative population,
the cross-sectional design of the study cannot provide infor-
mation on change over time. Nevertheless, a clustered risk
score is an accepted method of prediction of CVD risk [4].
All variables used in the clustered risk were taken into
account using the same weighting. Published data do not
indicate that one variable should be weighted more heavily
than another [4,5]. Although lifestyle variables did not
contribute to CVD risk prediction in this study, we should
be careful with the interpretation of this result because
lifestyle variables were measured by self-report. Finally,
the rather large percentage of obese and overweight subjects
compared with a normal population did not influence the
results, that is, the final regression model remained more or
less the same even when analyses were performed separately
for the body mass index groups (data not shown).Conclusion
Markers of inflammation and endothelial dysfunction
refine classical CVD risk prediction. Results not only confirm
a role for inflammation and endothelial dysfunction but also
Table 4
Regression models
Univariatea Multipleb
Be`ta (standardized) 95% CI p-value Be`ta (standardized) 95% CI p-value
Physical activity .081 .043 to .202 .201
Smoking status .037 .158. to .086 .599
Caloric intake per 100 kCals .002 .124 to.121 .981
sICAM .340 .23 to .44 <.001 .32 21 to .44 <.001
hsCRP .389 .28 to .49 <.001 .29 .18 to .40 <.001
sVCAM .161 .28 to .04 .010 .24 .36 to .16 <.001
a Interpretation of standardized regression coefficient (Be`ta) of for example physical activity (B ¼ .081): scoring 1SD higher in the physical activity score
results in a change of - .081 on the CVD risk score.
b The multiple regression model is the model that includes all significant predictors for CVD risk.
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point, conclusions to redirect the prevention of CVD are
preliminary and thus efforts should remain concentrated on
classical risk prediction and preventive strategies.Acknowledgments
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